Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Leukemia and NTRK3[original query] |
---|
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. Blood 2018 Jul . Roberts Kathryn G, Reshmi Shalini C, Harvey Richard C, Chen I-Ming, Patel Kinnari, Stonerock Eileen, Jenkins Heather, Dai Yunfeng, Valentine Marc, Gu Zhaohui, Zhao Yaqi, Zhang Jinghui, Payne-Turner Debbie, Devidas Meenakshi, Heerema Nyla A, Carroll Andrew J, Raetz Elizabeth A, Borowitz Michael J, Wood Brent L, Mattano Leonard A, Maloney Kelly W, Carroll William L, Loh Mignon L, Willman Cheryl L, Gastier-Foster Julie M, Mullighan Charles G, Hunger Stephen |
Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies. The Journal of clinical investigation 2018 6 128 (9): 3819-3825. Taylor Justin, Pavlick Dean, Yoshimi Akihide, Marcelus Christina, Chung Stephen S, Hechtman Jaclyn F, Benayed Ryma, Cocco Emiliano, Durham Benjamin H, Bitner Lillian, Inoue Daichi, Chung Young Rock, Mullaney Kerry, Watts Justin M, Diamond Eli L, Albacker Lee A, Mughal Tariq I, Ebata Kevin, Tuch Brian B, Ku Nora, Scaltriti Maurizio, Roshal Mikhail, Arcila Maria, Ali Siraj, Hyman David M, Park Jae H, Abdel-Wahab Om |
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement. Blood advances 2020 1 4 (1): 106-111. Nardi Valentina, Ku Nora, Frigault Matthew J, Dubuc Adrian M, Tsai Harrison Kwei, Amrein Philip C, Hobbs Gabriela S, Brunner Andrew M, Narayan Rupa, Burke Meghan E, Foster Julia, Dal Cin Paola, Maus Marcela V, Fathi Amir T, Hock Han |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: